Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Cancer Treatment Reviews|April 18, 2021
Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm?Timothée Olivier, Eugenio Fernandez, Intidhar Labidi-Galy, et al.Cell|March 4, 2014
Nuclear pores protect genome integrity by assembling a premitotic and Mad1-dependent anaphase inhibitorVeronica Rodriguez-Bravo, John Maciejowski, Jennifer Corona, et al.Journal of Visualized Experiments : Jove|April 2, 2014
Isolation of cancer stem cells from human prostate cancer samplesSamuel J Vidal, S Aidan Quinn, Janis de la Iglesia-Vicente, et al.Journal of Visualized Experiments : Jove|November 12, 2015
Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor CellsEstrelania S Williams, Veronica Rodriguez-Bravo, Veronica Rodriquez-Bravo, et al.Developmental Cell|April 26, 2017
Mps1 Regulates Kinetochore-Microtubule Attachment Stability via the Ska Complex to Ensure Error-Free Chromosome SegregationJohn Maciejowski, Hauke Drechsler, Kathrin Grundner-Culemann, et al.The Journal of Clinical Investigation|January 16, 2026
Reversing enhancer RNA-mediated IKBKE gene repression enables synthetic anticancer immunity in prostate cancer modelsXiang Li, Rui Sun, Hao Li, et al.Cancer Cell|September 15, 2012
Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cellsJosep Domingo-Domenech, Samuel J Vidal, Veronica Rodriguez-Bravo, et al.Cancer Discovery|July 25, 2025
Off-pore nucleoporin sPOM121 transcriptionally propels β-Catenin driven tumor progression and immune escape in prostate cancerPerumalraja Kirthika, Vijayakumar Jawalagatti, Peiyao Li, et al.Cell Reports. Medicine|February 14, 2023
Harnessing transcriptionally driven chromosomal instability adaptation to target therapy-refractory lethal prostate cancerBrittiny Dhital, Sandra Santasusagna, Perumalraja Kirthika, et al.Cancer Cell|February 12, 2015
A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancerSamuel J Vidal, Veronica Rodriguez-Bravo, S Aidan Quinn, et al.Pageof 3